An experimental new study has recently tested the efficacy of favipiravir (Avigan) for treating COVID-19. Recently, there has been much media speculation around the Japanese anti-flu drug favipiravir (brand name Avigan) being effective against SARS-CoV-2.
This is the virus that causes COVID-19. This is because Chinese officials announced in a press conference that the drug could effectively treat this virus. Since then, the results of one of the two clinical trials that the Chinese officials cited have become available.
We take a look at the findings and explain why people must interpret them with caution. Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and
Read more on medicalnewstoday.com